Comparative efficacy of subsequent-line therapies for advanced triple-negative breast cancer: a bayesian network meta-analysis.

As illustrated in Figure 3E , the pooled ADC class demonstrated significantly better PFS outcomes than 15 other regimens; four regimens showed a nonsignificant trend toward inferior efficacy relative to ADCs. 3.5.

also in 5,406 other papers

Figure 2E further shows that the pooled ADC class exhibited significantly higher efficacy than most of the other 16 regimens; although two regimens showed a trend toward lower efficacy compared with ADCs, none reached statistical significance. 3.4.

also in 53,322 other papers